GAD2 and epilepsy: Early immunotherapy is well known to induce a better response.[9, 16, 17] However, the anti-GAD65 antibody, which is often associated with immunotherapy-refractory epilepsy (19), was not assessed in our patients, which could have resulted in a better response to the immunotherapy.